Ustekinumab More Effective Than TNF-α Inhibitors in Psoriasis
Ustekinumab more effective than three tumor necrosis factor-α-inhibitors at six, 12 months
Aromatase Inhibitors Won’t Raise Odds of Most Fatal CVD Events
But there is a slightly increased risk of less serious cardiovascular issues
Anthracyclines May Not Trigger ‘Chemo Brain’
New research finds no link between the meds and survivors' cognitive function
Do Antihistamines Blunt Exercise Recovery?
Histamine blockade changes expression of genes that respond to exercise
Pembrolizumab Active in Patients With Advanced Melanoma
Overall response rate of 33 percent for total population, 45 percent among treatment naive
Improved Survival for Certain Cancers With Low-Dose Aspirin
Improved odds seen for patients with colon, prostate, or breast tumors, but research isn't definitive
AAN: Botulinum Toxin Approved for Use in Chronic Migraine
American Academy of Neurology issues new guideline on use of the drug
LDL Reduction in Hypertriglyceridemia Varies Per Statin
Greater LDL-C reductions for rosuvastatin 10-40 mg vs equal, double doses of atorvastatin, simvastatin
In Breast CA, Cardiotoxicity Up With Trastuzumab-Based Chemo
Increased risk of cardiotoxicity for trastuzumab with nonanthracycline chemo, sequential tx
Trichloroacetic Acid Beats Cryotherapy for Plantar Warts
Findings based on four weeks of treatment delivered by a physician
